German Pharmaceuticals & Biotech Mid-Large Cap Stocks

Merck KGaA

Market Cap: €63.9b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

Dermapharm Holding

Market Cap: €2.3b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

SCHOTT Pharma KGaA

Market Cap: €2.6b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Hamlet BioPharma

Market Cap: €1.4b

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Gerresheimer

Market Cap: €912.5m

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Bayer

Market Cap: €46.2b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.